Horizon Pharma Inc (NASDAQ:HZNP) up 24.6 percent to its new high after announcing that it and Vidara Therapeutics International Ltd. (Vidara) announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara through a reverse merger for stock and cash valued at approximately $660 million. Horizon Pharma Inc (NASDAQ:HZNP) shares after opening at $18.00 moved to $18.30 on last trade day and at the end of the day closed at $16.02. Company price to sales ratio in past twelve months was calculated as 19.04 and price to cash ratio as 17.64. Horizon Pharma Inc (NASDAQ:HZNP) showed a positive weekly performance of 17.62%.
Famous Dave’s Of America, Inc. (NASDAQ:DAVE) COO Christopher Odonnell unloaded 49,177 shares of Famous Dave’s Of America, Inc. stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $28.46, for a total value of $1,399,577.42. Famous Dave’s of America, Inc. (NASDAQ:DAVE) shares advanced 0.42% in last trading session and ended the day on $ 30.94. DAVE return on equity ratio is recorded as 10.80% and its return on assets is 5.00%. Famous Dave’s of America, Inc. (NASDAQ:DAVE) yearly performance is 186.48%.
Federated Nat (NASDAQ:FNHC) Chairman Bruce Simberg purchased 5,040 shares of Federated Nat stock in a transaction that occurred on Monday, March 17th. The stock was purchased at an average cost of $16.28 per share, with a total value of $82,051.20. Federated National Holding Co (NASDAQ:FNHC) shares moved up 0.53% in last trading session and was closed at $16.99 while trading in range of $16.89 – $17.24 – Federated National Holding Co (NASDAQ:FNHC) year to date (YTD) performance is 16.05%.
Albany Molecular Research (NASDAQ:AMRI) was upgraded by equities research analysts at TheStreet from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Analyst Ratings.Netreports. Albany Molecular Research, Inc. (NASDAQ:AMRI) weekly performance is 21.87%. On last trading day company shares ended up $19.78. Albany Molecular Research, Inc. (NASDAQ:AMRI) distance from 50-day simple moving average (SMA50) is 51.78%. Analysts mean target price for the company is $13.00.
Leave a Reply